Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)

N. J. Short, H. Rafei, N. Daver

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)'. Together they form a unique fingerprint.

Medicine & Life Sciences